# Inhibikase Therapeutics, Inc.: Form DEF 14A, filed Jun 20, 2024

- Company: [Inhibikase Therapeutics, Inc.](/companies/ikt.md) (CIK 1750149)
- Form: DEF 14A
- Filed: 2024-06-20
- Accepted by EDGAR: Jun 20, 2024, 22:06 ET
- Period: 2024-08-05
- Accession: 0000950170-24-075675
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1750149/000095017024075675/ikt-proxy_special-2024_d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750149/000095017024075675/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750149/000095017024075675/ikt-proxy_special-2024_d.htm

Filed Jun 20, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-075675. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.